European Study of Dronedarone in Atrial Fibrillation

Inclusion Criteria: * Patients with symptomatic permanent AF (\>6 months) for which cardioversion is not considered and resting ventricular rate \> or equal 80 bpm at screening measured on a 6-seconds rhythm strip, Exclusion Criteria: * Unstable angina pectoris, recent myocardial infarction or history of torsades de pointes * Third degree atrioventricular block at the screening ECG or significant sinus node disease without a permanent pacemaker implanted * Clinically overt congestive heart failure at randomization * Patients treated with amiodarone, other antiarrhythmic drugs or previous participation in this trial or in other dronedarone trials or taking an investigational drug * Clinically relevant haematologic, hepatic, gastro-intestinal, renal, pulmonary, endocrinologic or psychiatric disease * Pregnant and/or breastfeeding women or women of child-bearing potential with no adequate birth control The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.